Clinical Trial

A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to build on the experience of the SAINT trial by evaluating the safety and efficacy of the addition of pazopanib to their published chemotherapy regimen.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-19
Trial Details
NCT Number NCT07444619
Lead Sponsor M.D. Anderson Cancer Center
Conditions Soft Tissue Sarcomas
Enrollment 18 participants
Start Date 2026-06-12
Primary Completion 2031-12-31 (estimated)
Study Completion 2033-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-06